PLIVA is Croatia’s largest pharmaceutical company and one of the leading companies in Southeast Europe, supported by a large community of experts, researchers and scientists, innovative technology and continuous investment in production. With more than 100 years of successful pharmaceutical experience, PLIVA is now part of the TEVA Group, one of the world’s largest pharmaceutical companies.
Over many years, we designed more than 30 different facilities within PLIVA. Our role included MEP design and coordination of all building services from the initial concept through commissioning, while meeting the demanding standards of the pharmaceutical industry, including GMP.
The MEP scope primarily involved the highly demanding design of cleanrooms with various cleanliness classifications, as well as laboratories.
Some of the most important and demanding facilities include:
- Production of Solid Oral Dosage Forms, Zagreb
- Azithromycin Production, Savski Marof
- New Research Institute, Zagreb
- Multipurpose Biopharmaceutical Facility SMJ 1790, Savski Marof
- Geomycin Retard Production
- Construction of the New TAPI Quality Building, Savski Marof
- Sulfonamide Production Facility, Areas A–F, Zagreb
- Mupirocin Production
- Quality Control Laboratory, Zagreb, and others